Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Stability Testing Under Accelerated Conditions – V 2.0

Posted on By

SOP for Stability Testing Under Accelerated Conditions – V 2.0

Procedure for Stability Testing Under Accelerated Conditions

Department Quality Control (QC)/Quality Assurance (QA)/Analytical Development
SOP No. SOP/Ointment/069
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the method for conducting stability testing under accelerated conditions to evaluate the shelf-life, physical, chemical, and microbiological stability of ointments.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Analytical Development departments responsible for conducting accelerated stability testing of ointments during formulation development, validation, and routine batch release.

3. Responsibilities

  • Quality Control Analyst: Conducts stability testing and records results.
  • Quality Assurance Personnel: Reviews and approves test results.
  • Stability Study Coordinator: Manages stability chamber conditions and sample tracking.
  • R&D and Analytical Development Team: Evaluates formulation modifications based on stability test results.
See also  Ointments: SOP for Conducting CIP (Clean in Place) in Machines - V 2.0

4. Accountability

The QC, Stability Study, and QA Managers are accountable for ensuring that stability testing is conducted accurately and documented as per ICH and GMP guidelines.

5. Procedure

5.1 Equipment and Materials

  • Stability chambers with temperature and humidity control
  • HPLC system for assay and degradation analysis
  • pH meter
  • Viscometer
  • Microbial testing equipment
  • Data recording sheets

5.2 Sample Preparation

  • Select representative samples from different production batches.
  • Store samples in appropriate stability study containers.
  • Label each sample
with batch number, storage conditions, and testing intervals.

5.3 Stability Storage Conditions

  • Accelerated Conditions: 40°C ± 2°C / 75% RH ± 5% for 6 months
  • Intermediate Conditions (if required): 30°C ± 2°C / 65% RH ± 5% for 12 months
  • Long-Term Conditions: 25°C ± 2°C / 60% RH ± 5% for 24 months

5.4 Stability Testing Parameters

5.4.1 Physical Tests

  • Appearance: No color or texture changes should occur.
  • Phase Separation: Check for oil-water phase separation.
  • Viscosity: Measure using a viscometer.

5.4.2 Chemical Tests

  • Assay: Determine API concentration using HPLC.
  • Degradation Products: Analyze degradation peaks.
  • pH: Ensure no significant variation from the initial value.

5.4.3 Microbiological Tests

  • Total Aerobic Microbial Count (TAMC): Should comply with specifications.
  • Total Yeast and Mold Count (TYMC): Should comply with specifications.
  • Pathogen Testing: Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa should be absent.

5.5 Stability Testing Schedule

  • Samples should be tested at the following intervals:
    • Initial (T0)
    • 1 Month (T1)
    • 3 Months (T3)
    • 6 Months (T6)
  • For long-term studies, additional testing may be conducted at 9, 12, 18, and 24 months.

5.6 Acceptance Criteria

  • No significant change in physical, chemical, or microbiological properties.
  • API content should remain within ±5% of initial assay value.
  • Degradation products should remain within acceptance limits.

5.7 Documentation

  • Record all stability test results in the Stability Test Log.
  • Document environmental conditions of the stability chambers.
  • QA personnel must review and approve results before batch release.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • RH – Relative Humidity
  • ICH – International Council for Harmonisation

7. Documents

  • Stability Test Log (Annexure-1)
  • Ointment Stability Report (Annexure-2)

8. References

  • ICH Q1A(R2) – Stability Testing of New Drug Substances and Products
  • WHO Stability Testing Guidelines
  • USP <1225> – Validation of Compendial Methods

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Test Log

Date Batch Number Storage Condition Time Point Assay (%) pH Viscosity Result Verified By
01/02/2025 OINT-101 40°C/75% RH 3M 98.5% 6.2 45,000 cP Pass QA Officer
02/02/2025 OINT-102 40°C/75% RH 6M 97.2% 6.1 44,500 cP Pass QA Officer

Annexure-2: Ointment Stability Report

Date Batch Number Storage Condition Acceptance Criteria Result Final Status Approved By
01/02/2025 OINT-101 40°C/75% RH No significant change Pass Approved QA Head
02/02/2025 OINT-102 40°C/75% RH No significant change Pass Approved QA Head

12. Revision History:

Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Preparing Formulations for Preclinical Testing
Next Post: SOP for Particle Size Analysis in Formulation Screening

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version